Literature DB >> 7917362

The c-erbA beta thyroid hormone receptor. Expression and cDNA sequence analysis of the hormone-binding domain in human cancer cell lines.

V T Chow1, S S Lim, E P Tock.   

Abstract

The human c-erbA beta protooncogene encodes a thyroid hormone receptor (comprising a hormone-binding domain and a DNA-binding domain) which modulates expression of specific genes, such as cell differentiation genes. Using the reverse transcription and polymerase chain reaction (RT-PCR) assay, significant expression of the c-erbA beta gene was detected in the SiHa, CaSki, HeLa cervical carcinoma; Hep3B, PLC/PRF/5, Mahlavu hepatocellular carcinoma; HT-1080 fibrosarcoma cell lines; as well as in normal MRC-5 embryo lung and FS-4 foreskin fibroblast cell lines. However, the Molt-4 leukaemia and Raji Burkitt's lymphoma cell lines exhibited very low levels of c-erbA beta expression. Single-strand conformation polymorphism analysis and direct sequencing of PCR products of the c-erbA beta hormone-binding domain cDNAs of these cell lines revealed identical sequences, but differed from the published human placental c-erbA beta sequence by five single base disparities. Sequencing of an aberrant fragment fortuitously amplified from the HT-1080 cDNA library demonstrated concordance with the cDNA of pregnancy-specific glycoprotein 4, which is related to the tumour marker, carcinoembryonic antigen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917362     DOI: 10.3109/02841869409083925

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  1 in total

1.  Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy.

Authors:  Rohit Anthony Sinha; Seo-Hee You; Jin Zhou; Mobin M Siddique; Boon-Huat Bay; Xuguang Zhu; Martin L Privalsky; Sheue-Yann Cheng; Robert D Stevens; Scott A Summers; Christopher B Newgard; Mitchell A Lazar; Paul M Yen
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.